vimarsana.com

Page 2 - ஒன்றுபட்டது கிஂக்டம் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020 ACCESSWIRE Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2020. Following the announcement of a Strategic Review in March 2020 and the termination of further in-house development of MTD201, the Company has broadened its R&D pipeline through technology collaborations with third party pharmaceutical companies, the initiation of new internal programmes and adding new indications to MTX110.

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020

Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020 Preliminary Results for the Year Ended 31 December 2020 ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 30, 2021 / Midatech Pharma PLC (AIM:MTPH.L); (NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the year ended 31 December 2020. Following the announcement of a Strategic Review in March 2020 and the termination of further in-house development of MTD201, the Company has broadened its R&D pipeline through technology collaborations with third party pharmaceutical companies, the initiation of new internal programmes and adding new indications to MTX110. The Company s realigned strategy is to advance its development programmes to proof of concept stage before seeking licensee partners to fund further development, manufacturing scale-up and commercialisation.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.